| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.087 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |